LOSS PER SHARE (Tables)

6 Months Ended

Jun. 30, 2023

Schedule of Computation of Basic and Diluted (Loss) Earnings per Share

The following table sets forth the computation of basic and diluted loss per share attributable to Angi Inc. Class A and Class B Common Stock shareholders:


	Three Months Ended June 30,
	2023				2022
	Basic		Diluted		Basic		Diluted
	(In thousands, except per share data)
Numerator:
Net loss	$	(14,479)	$	(14,479)	$	(23,997)	$	(23,997)
Net earnings attributable to noncontrolling interests	(220)		(220)		(235)		(235)
Net loss attributable to Angi Inc. Class A and Class B Common Stock shareholders	$	(14,699)	$	(14,699)	$	(24,232)	$	(24,232)

Denominator:
Weighted average basic Class A and Class B common stock shares outstanding	506,086		506,086		502,453		502,453
Dilutive securities (a) (b)	—		—		—		—
Denominator for loss per share—weighted average shares	506,086		506,086		502,453		502,453

Loss per share attributable to Angi Inc. Class A and Class B Common Stock shareholders:
Loss per share	$	(0.03)	$	(0.03)	$	(0.05)	$	(0.05)


	Six Months Ended June 30,
	2023				2022
	Basic		Diluted		Basic		Diluted
	(In thousands, except per share data)
Numerator:
Net loss	$	(29,479)	$	(29,479)	$	(57,284)	$	(57,284)
Net earnings attributable to noncontrolling interests	(545)		(545)		(338)		(338)
Net loss attributable to Angi Inc. Class A and Class B Common Stock shareholders	$	(30,024)	$	(30,024)	$	(57,622)	$	(57,622)

Denominator:
Weighted average basic Class A and Class B common stock shares outstanding	505,563		505,563		502,231		502,231
Dilutive securities (a) (b)	—		—		—		—
Denominator for loss per share—weighted average shares	505,563		505,563		502,231		502,231

Loss per share attributable to Angi Inc. Class A and Class B Common Stock shareholders:
Loss per share	$	(0.06)	$	(0.06)	$	(0.11)	$	(0.11)

________________________

(a) If the effect is dilutive, weighted average common shares outstanding include the incremental shares that would be issued upon the assumed exercise of stock options and subsidiary denominated equity and vesting of restricted stock units (“RSUs”). For the three and six months ended June 30, 2023 and 2022, 28.1 million and 28.7 million of potentially dilutive securities, respectively, were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive. Accordingly, the weighted average basic shares outstanding were used to compute all earnings per share amounts.

(b) Market-based awards and performance-based stock units (“PSUs”) are considered contingently issuable shares. Shares issuable upon exercise or vesting of market-based awards and PSUs are included in the denominator for earnings per share if (i) the applicable market or performance condition(s) has been met and (ii) the inclusion of the market-based awards and PSUs is dilutive for the respective reporting periods. For the three and six months ended June 30, 2023 and 2022, 0.7 million and 4.4 million underlying market-based awards and PSUs, respectively, were excluded from the calculation of diluted earnings per share because the market or performance condition(s) had not been met.